DSO – Trefoil therapeutics

Tag: DSO

March 10, 2021

Price Vision Group Participating in Clinical Study of Investigational Growth Factor Treatment for Eye Disorder, Fuchs Endothelial Corneal Dystrophy

Indianapolis, IN – March 10, 2021 – Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use of an experimental drug treatment in conjunction with a surgical procedure that

February 9, 2021

Trefoil Therapeutics Begins Second Phase 2 “STORM” Clinical Trial with Regenerative Treatment for Fuchs Endothelial Corneal Dystrophy

Study evaluating engineered FGF-1’s (TTHX114) potential in patients undergoing Descemet Stripping Only (DSO or DWEK) procedures San Diego, CA – February 9, 2021 – Trefoil Therapeutics today announced it has begun a Phase 2 clinical trial of its engineered Fibroblast